bioMerieux S.A. | Ownership
Companies that own bioMerieux S.A.
Jupiter Asset Management Ltd.
5,217,319
4.41%
147,000
1.43%
05/31/2018
Oddo BHF Asset Management SAS
1,719,092
1.45%
294,050
1.4%
04/30/2018
Norges Bank Investment Management
1,539,869
1.3%
-363,193
0.02%
12/31/2017
The Vanguard Group, Inc.
1,084,486
0.92%
6,409
0%
07/31/2018
OppenheimerFunds, Inc.
866,120
0.73%
-15,330
0.04%
02/28/2018
BlackRock Fund Advisors
714,869
0.6%
2,779
0%
09/06/2018
Candriam Belgium SA
607,720
0.51%
71,920
0.23%
07/31/2018
Capital Research & Management Co. (Global Investors)
577,000
0.49%
-25,700
0.01%
06/30/2018
La Banque Postale Asset Management SA
404,109
0.34%
11,230
0.16%
08/31/2018
Capital Research & Management Co. (World Investors)
365,755
0.31%
-10,280
0.01%
06/30/2018
| Address |
376, chemin de l'Orme
Marcy l'Etoile Rhone-Alpes 69280
France
|
|
Employees
|
- |
| Website |
http://www.biomerieux.com |
| Updated |
07/08/2019 |
| bioMérieux SA engages in the provision of diagnostic solutions which determine the source of disease and contamination. The company provides clinical solutions such as antimicrobial resistance, C. difficile infection, human immunodeficiency virus, and emergency department patient management. |
